Amplia Therapeutics appointed Mr. Brett Carter as a non-executive director effective 6 July 2026. No financial targets, guidance, or operational changes were disclosed, so the update is likely routine for investors.
Amplia Therapeutics appointed Mr. Brett Carter as a non-executive director effective 6 July 2026. No financial targets, guidance, or operational changes were disclosed, so the update is likely routine for investors.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
neutral
Sentiment Score
0.05
Ticker Sentiment
